Research Article
FKBP4 Accelerates Malignant Progression of Non-Small-Cell Lung Cancer by Activating the Akt/mTOR Signaling Pathway
Figure 11
mTOR inhibitor neutralizes the functions of FKBP4 in NSCLC cells. The PC-9 cells transfected with FKBP4 overexpression plasmids were treated with mTOR inhibitor rapamycin (200 nmol/l). Cell proliferation, apoptosis, migration, and invasion were analyzed by the CCK8 assay (a), flow cytometry (b), scratch test (c), and Transwell experiment (d), respectively; , .
(a) |
(b) |
(c) |
(d) |